Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1974-09-19
1977-07-05
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 424 15, 424 12, G01N 3300, G21H 502, A61B 1000
Patent
active
040340740
ABSTRACT:
An improvement is made in 2-site immunoradiometric assay wherein a single labelled antibody can be used to assay many different antigens.
REFERENCES:
patent: 3904367 (1975-09-01), Golibersuch
Catt, Acta Endocrinologica Supplementum, No. 142, 1969, pp. 222-246.
Addison et al., Hormone and Metabolic Research, vol. 3, No. 1, Jan., 1971, pp. 59-60.
Midgley et al., Acta Endocrinologica Supplementum, No. 142, 1969, pp. 247-256.
Silman et al., Annual Review of Biochemistry, vol. 35, part II, 1966, pp. 873-880.
Miles et al., Nuclear Science Abstracts, vol. 30, No. 11, Dec. 15, 1974, abstract No. 29835.
Nucker Christine M.
Padgett Benjamin R.
Slick Robert G.
The Board of Trustees of Leland Stanford Junior University
LandOfFree
Universal reagent 2-site immunoradiometric assay using labelled does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Universal reagent 2-site immunoradiometric assay using labelled , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Universal reagent 2-site immunoradiometric assay using labelled will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-578158